These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 37001946)
21. Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment. Wang X; Chi X; Wu R; Xu H; Gao X; Yu L; Liu L; Zhang M; Tan Y; Niu J; Jin Q Virol J; 2021 Jan; 18(1):4. PubMed ID: 33407619 [TBL] [Abstract][Full Text] [Related]
22. [Analysis and significance of HBV DNA below the lower detection limit of HBV RNA levels after long-term NAs antiviral therapy in patients with hepatitis B virus cirrhosis]. Wang CY; Cao Y; Feng YM; Li J; Jiang B; Zhang Y; Wen J; Zhu YJ; Li J Zhonghua Gan Zang Bing Za Zhi; 2022 Jul; 30(7):758-762. PubMed ID: 36038347 [No Abstract] [Full Text] [Related]
23. Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation. Seto WK; Liu KS; Mak LY; Cloherty G; Wong DK; Gersch J; Lam YF; Cheung KS; Chow N; Ko KL; To WP; Fung J; Yuen MF Gut; 2021 Apr; 70(4):775-783. PubMed ID: 32759300 [TBL] [Abstract][Full Text] [Related]
24. Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogue. Ramji A; Doucette K; Cooper C; Minuk GY; Ma M; Wong A; Wong D; Tam E; Conway B; Truong D; Wong P; Barrett L; Ko HH; Haylock-Jacobs S; Patel N; Kaplan GG; Fung S; Coffin CS World J Gastroenterol; 2022 Aug; 28(31):4390-4398. PubMed ID: 36159017 [TBL] [Abstract][Full Text] [Related]
28. The role of HBsAg quantification for monitoring natural history and treatment outcome. Martinot-Peignoux M; Lapalus M; Asselah T; Marcellin P Liver Int; 2013 Feb; 33 Suppl 1():125-32. PubMed ID: 23286856 [TBL] [Abstract][Full Text] [Related]
29. [Nucleos(t)ides as prophylaxis for the reactivation of hepatitis B virus in immunosuppressed patients]. Fan LY; Zhou Z; Zhong S; Ling N; Wang ZY; Shi XF; Zhang DZ; Ren H Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):429-33. PubMed ID: 19567021 [TBL] [Abstract][Full Text] [Related]
30. Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in Japan. Suzuki F; Hosaka T; Suzuki Y; Sezaki H; Akuta N; Fujiyama S; Kawamura Y; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Mineta R; Suzuki Y; Kumada H J Gastroenterol; 2019 Feb; 54(2):182-193. PubMed ID: 30136216 [TBL] [Abstract][Full Text] [Related]
31. [Research progress of biomarkers of hepatitis B virus and clinical significance]. Wang X; Tang X; Han N; Tang H Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2023 Dec; 40(6):1242-1248. PubMed ID: 38151949 [TBL] [Abstract][Full Text] [Related]
32. How to interpret viral markers in the management of chronic hepatitis B infection. Riveiro-Barciela M; Pericàs JM; Buti M Clin Microbiol Infect; 2022 Mar; 28(3):355-361. PubMed ID: 34768018 [TBL] [Abstract][Full Text] [Related]
33. Detection technology and clinical applications of serum viral products of hepatitis B virus infection. Liu Y; Wu D; Zhang K; Ren R; Liu Y; Zhang S; Zhang X; Cheng J; Chen L; Huang J Front Cell Infect Microbiol; 2024; 14():1402001. PubMed ID: 39035352 [TBL] [Abstract][Full Text] [Related]
34. [New insight for HBV DNA and HBsAg quantitation during antiviral therapy in patients with chronic hepatitis B]. Cho YK; Song BC Korean J Gastroenterol; 2011 Mar; 57(3):144-9. PubMed ID: 21519161 [TBL] [Abstract][Full Text] [Related]
35. Current view on hepatitis B diagnosis and therapy. Husa P Vnitr Lek; 2021; 67(1):48-50. PubMed ID: 33752391 [TBL] [Abstract][Full Text] [Related]
36. Prevention of hepatocellular carcinoma in hepatitis B virus infection. Lim SG; Mohammed R; Yuen MF; Kao JH J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903 [TBL] [Abstract][Full Text] [Related]
37. Predictors of treatment response in chronic hepatitis B. Wong GL; Chan HL Drugs; 2009 Nov; 69(16):2167-77. PubMed ID: 19852523 [TBL] [Abstract][Full Text] [Related]
38. The prognosis and management of inactive HBV carriers. Invernizzi F; Viganò M; Grossi G; Lampertico P Liver Int; 2016 Jan; 36 Suppl 1():100-4. PubMed ID: 26725905 [TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B. Fung J; Lai CL; Yuen MF Expert Rev Anti Infect Ther; 2010 Jun; 8(6):717-26. PubMed ID: 20521898 [TBL] [Abstract][Full Text] [Related]